Matthew Triplette joins inaugural cohort of cancer moonshot scholars

Dr. Matthew Triplette, associate professor (Pulmonary, Critical Care and Sleep Medicine) has been selected for the inaugural cohort of Cancer Moonshot Scholars, a program launched by President Biden last year to support early-career researchers and help build a cancer research workforce that better represents the diversity of America.

The Biden-Harris Administration, through the National Cancer Institute, is committing $5.4 million in the first year of these multi-year awards to support the inaugural cohort of 11 Cancer Moonshot Scholars.

These emerging leaders in cancer research and innovation will use this funding to help change what is possible, with projects to increase prevention and early detection efforts for patients from underrepresented populations, create new cancer treatments for all Americans, and further the nation’s expertise in addressing hard-to-treat cancers.

As one of the inaugural scholars, Triplette will be evaluating the barriers and facilitators of lung cancer screening adherence in decentralized programs, in order to adapt and measure the impact of interventions on adherence.

"I'm humbled and honored to be a part of this amazing group of scholars, and grateful to the National Cancer Institute and the White House for recognizing the value of diversity, in all its forms, to cancer science," said Triplette.